These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 16625721)

  • 21. US and Thai Governments defend HIV/AIDS vaccine trial in Thailand.
    Agnew B
    Bull World Health Organ; 2004 Mar; 82(3):231. PubMed ID: 15112014
    [No Abstract]   [Full Text] [Related]  

  • 22. Trial for preventive HIV vaccine enrolls 2500 volunteers.
    AIDS Read; 2000 Oct; 10(10):580. PubMed ID: 11068803
    [No Abstract]   [Full Text] [Related]  

  • 23. Kenya begins enrollment for Phase I vaccine trial.
    IAVI Rep; 2006; 10(1):20. PubMed ID: 16625722
    [No Abstract]   [Full Text] [Related]  

  • 24. NIAID begins enrolling volunteers for Phase IIB study of Merck's vaccine.
    IAVI Rep; 2004 Dec-2005 Mar; 9(1):16. PubMed ID: 16114115
    [No Abstract]   [Full Text] [Related]  

  • 25. Vaccines and immunology: elucidating immunity to HIV-1 and current prospects for AIDS vaccine development.
    Heeney JL; Hahn BH
    AIDS; 2000; 14 Suppl 3():S125-7. PubMed ID: 11086855
    [No Abstract]   [Full Text] [Related]  

  • 26. Adaptive clinical trial designs proposed to accelerate development of HIV vaccines.
    Expert Rev Vaccines; 2011 Jun; 10(6):717. PubMed ID: 21692694
    [No Abstract]   [Full Text] [Related]  

  • 27. U.S. Congress to consider vaccine-focused legislation.
    IAVI Rep; 2007; 11(1):19. PubMed ID: 20210122
    [No Abstract]   [Full Text] [Related]  

  • 28. Human trials of experimental HIV vaccines.
    Burke DS
    AIDS; 1995; 9 Suppl A():S171-80. PubMed ID: 8819583
    [No Abstract]   [Full Text] [Related]  

  • 29. Three new AIDS vaccine trials begin testing novel concepts.
    Doepel LK
    NIAID AIDS Agenda; 1998 Mar; ():8-9. PubMed ID: 11365091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The RV144 Thai HIV vaccine trial.
    Plotkin SA
    Hum Vaccin; 2010 Feb; 6(2):159. PubMed ID: 20431337
    [No Abstract]   [Full Text] [Related]  

  • 31. Companies begin tests of HIV vaccines.
    Niiler E
    Nat Med; 2001 Apr; 7(4):390. PubMed ID: 11283644
    [No Abstract]   [Full Text] [Related]  

  • 32. AIDS 1999. Vaccines and immunology: overview.
    Stott J; Hahn BH
    AIDS; 1999; 13 Suppl A():S103-4. PubMed ID: 10885768
    [No Abstract]   [Full Text] [Related]  

  • 33. Vaccine trial discontinued.
    AIDS Patient Care STDS; 2007 Oct; 21(10):778-9. PubMed ID: 17992718
    [No Abstract]   [Full Text] [Related]  

  • 34. AIDS 1997. Vaccines and immunology: overview.
    Hu S; Norrby E
    AIDS; 1997; 11 Suppl A():S85-6. PubMed ID: 9451971
    [No Abstract]   [Full Text] [Related]  

  • 35. First AIDS vaccine trial begins in Africa.
    AIDS Patient Care STDS; 1999 May; 13(5):309-10. PubMed ID: 10356817
    [No Abstract]   [Full Text] [Related]  

  • 36. Trial evaluating DNA/Ad35 prime-boost regimen commences in Africa.
    McEnery R
    IAVI Rep; 2012; 16(1):17. PubMed ID: 22442883
    [No Abstract]   [Full Text] [Related]  

  • 37. Novel adjuvants and delivery systems for HIV vaccines.
    O'Hagan DT; Lavelle E
    AIDS; 2002; 16 Suppl 4():S115-24. PubMed ID: 12699008
    [No Abstract]   [Full Text] [Related]  

  • 38. Phase II prime-boost trial begins in the U.S.
    McEnery R
    IAVI Rep; 2009; 13(4):18. PubMed ID: 20225577
    [No Abstract]   [Full Text] [Related]  

  • 39. [An update and the outlook in vaccination against HIV/AIDS].
    Ivan A; Azoicăi D; Mitroi I
    Rev Med Chir Soc Med Nat Iasi; 1991; 95(1-2):207-10. PubMed ID: 1823419
    [No Abstract]   [Full Text] [Related]  

  • 40. NIAID and Merck to collaborate on HIV vaccine development.
    AIDS Read; 2002 Feb; 12(2):60. PubMed ID: 11905140
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.